1. Home
  2. SRTA vs EOLS Comparison

SRTA vs EOLS Comparison

Compare SRTA & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

HOLD

Current Price

$5.49

Market Cap

530.4M

Sector

N/A

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$8.25

Market Cap

529.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
EOLS
Founded
2014
2012
Country
United States
United States
Employees
N/A
353
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
530.4M
529.1M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
SRTA
EOLS
Price
$5.49
$8.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$7.81
$15.50
AVG Volume (30 Days)
680.8K
908.6K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
242.86
1.23
EPS
N/A
N/A
Revenue
$197,141,000.00
$297,176,000.00
Revenue This Year
$39.27
$13.27
Revenue Next Year
$8.52
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$3.95
$3.86
52 Week High
$6.50
$9.31

Technical Indicators

Market Signals
Indicator
SRTA
EOLS
Relative Strength Index (RSI) 46.16 48.81
Support Level $5.35 $7.59
Resistance Level $5.48 $8.43
Average True Range (ATR) 0.18 0.34
MACD -0.00 -0.14
Stochastic Oscillator 58.89 27.33

Price Performance

Historical Comparison
SRTA
EOLS

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: